Search
Home
About
Journals
News
Publish with us
Sign in
Fibrosis
Menu
About
Aim & Scope
Editorial Board
Indexing & Archiving
Article Processing Charge
News
Open Access Policy
Editorial Policy
Editorial Office
Articles
Current lssue
Issue Archives
Special lssues
Guide for Authors
Submit to Fibrosis
The Therapeutic Potential of Novel and Emerging Anti-fibrotic Drugs
Deadline for manuscript submissions:
30 March 2026
.
Guest Editors (3)
Dr. Jane Bourke
Department of Pharmacology, Biomedicine Discovery Institute, Monash University, Melbourne, 3168, VIC, Australia
Interests:
Airway; Bronchodilator; Precision Cut Lung Slice; Asthma; Fibrosis; Silicosis; COPD; Pharmacology
Website:
https://research.monash.edu/en/persons/jane-bourke
Prof. Chrishan S. Samuel
Cardiovascular Disease Program, Monash Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, VIC, Australia
Interests:
Cardiovascular Fibrosis; Kidney Fibrosis; Airway/Lung Fibrosis; Peptide therapeutics; Stem Cells; Epithelial Repair Factors; Animal Models; Myofibroblast Signal Transduction
Website:
https://research.monash.edu/en/persons/chrishan-samuel
Prof. Robert Widdop
Cardiovascular Disease Program, Monash Biomedicine Discovery Institute, and Department of Pharmacology, Monash University, Clayton VIC, Australia
Interests:
Renin Angiotensin System; Hypertension; Cardiovascular Disease; Renal Disease; Fibrotic Biomarkers
Website:
https://www.monash.edu/discovery-institute/widdop-lab/home
Topic Collection Information
Published Papers (0 papers)
TOP
Message
×